Science Explorer Interactive view Map
Hospital / health system · Pismo Beach · United States

PCR Oncology

Research works
22
▼ 6% vs 2013–17
Citations
849
39.1 per fractional work
Top-10% rate
0.0%
record average 16.5%
Open access
33%
world 28%

Not ranked overall: PCR Oncology is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 1.21× its world share, 0 worksBiochemistry, Geneti…Immunology and Microbiology: 1.22× its world share, 0 worksImmunology and Micro…Chemistry: 3.92× its world share, 0 worksChemistryComputer Science: 3.17× its world share, 1 worksComputer ScienceMedicine: 2.88× its world share, 3 worksMedicineSocial Sciences: 0.49× its world share, 0 worksSocial Sciencesworld share
more than its size predictsabout as predictedless

Rings at 0.5×, and 2×. Widest outward: Chemistry, 3.9×. Every wedge is a field page.

Which keywords describe research at PCR Oncology?

By fractional works in all years, weighted toward what it does more of than the world: Epidemiology, Therapeutic Targets, Treatment, Diagnostic Criteria, Innate Immunity, Prognostic Factors, Immunotherapy and Chemotherapy.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 13 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 13 words, with their numbers
  1. Epidemiology2▲ 2.8×11 topics
  2. Treatment1▲ 5.0×6 topics
  3. Inflammation1▲ 2.3×7 topics
  4. Therapeutic Targets1▲ 23×3 topics
  5. Chemotherapy1▲ 7.0×10 topics
  6. Deep Learning1▲ 2.3×4 topics
  7. Diagnostic Criteria1▲ 24×2 topics
  8. Immunotherapy1▲ 7.4×10 topics
  9. Innate Immunity1▲ 14×2 topics
  10. Prognostic Factors1▲ 11×5 topics
  11. Chronic Fatigue Syndrome1▲ 185×1 topic
  12. Fibromyalgia1▲ 185×1 topic
  13. Traumatic Brain Injury1▲ 45×2 topics

Which research topics does PCR Oncology publish most on?

By volume in 2022–2025: Chronic Lymphocytic Leukemia Research, HIV/AIDS drug development and treatment, Face recognition and analysis and Hand Gesture Recognition Systems.

  1. 1 Chronic Lymphocytic Leukemia Research Genetics 0 works
  2. 2 HIV/AIDS drug development and treatment Infectious Diseases 0 works
  3. 3 Face recognition and analysis Computer Vision and Pattern Recognition 0 works
  4. 4 Hand Gesture Recognition Systems Human-Computer Interaction 0 works
  5. 5 Computational Drug Discovery Methods Computational Theory and Mathematics 0 works
  6. 6 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 0 works
  7. 7 Academic Research in Diverse Fields Education 0 works
  8. 8 Click Chemistry and Applications Organic Chemistry 0 works
  9. 9 Human Pose and Action Recognition Computer Vision and Pattern Recognition 0 works
  10. 10 Ubiquitin and proteasome pathways Molecular Biology 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available33.2%not open66.8%

World: 28% of research is openly available.

with international co-authors41.8%domestic only58.2%

World: 19% is written across borders.

How has PCR Oncology's research output changed?

Output in 2018–2022 was 6% lower than in 2013–2017.

1990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.